TMCnet News
OURA Expands Healthcare Research With First Clinical Trial Exploring GLP-1 Treatment OutcomesOURA, a health intelligence platform and maker of the world's smallest smart ring, today announced the launch of SMART-BMI, its first clinical trial, in collaboration with UC San Diego Health, examining outcomes from GLP-1 treatment and bariatric surgery. The multi-year study is the latest addition to Oura's growing work in healthcare research, scientific validation, and outcomes measurement, led by the Office of Regulatory and Clinical Affairs (ORCA), which was built over the past year under Chief Medical Officer Dr. Ricky Bloomfield. Studying what happens between visits GLP-1 medications and bariatric surgery are among the most widely used approaches to treating obesity, but much of what happens between care visits, including how patients sleep, recover, and move, is rarely captured. SMART-BMI is designed to help close that gap. The multi-year study will examine how physiological changes measured by Oura Ring, such as sleep, heart rate, and activity, are associated with obesity treatment outcomes. It will capture changes between care visits and examine associations with outcomes including weight loss, HbA1c, and treatment persistence. The study is registered at ClinicalTrials.gov, NCT07736729. "Longitudinal and surgical management of obesity can unlock the power of continuous monitoring and precision medicine offered by wearables," said Jeff Reeves, MD, UC San Diego Health. "UC San Diego Health is precisely where innovative technology and subject matter experts come together to advance human health," added Alexander Khalessi, neurosurgeon and chief innovation officer at UC San Diego Health. "We are proud of the thought leadership of Dr. Reeves and Oura's engagement to take on these important clinical questions for our patients." ORCA in practice Formalized over the past year under the leadership of Chief Medical Officer Dr. Ricky Bloomfield, the ORCA team brings together work Oura has been advancing for several years across clinical, regulatory, outcomes research, and informatics. By unifying these efforts, ORCA connects the core functions Oura needs to move continuous health data from measurement to evidence-and ultimately, to responsible use in care. ORCA's work is organized around four connected disciplines:
"Since I started at Oura, my focus has been on formalizing the clinical rigor behind the trust people already place in their ring," said Dr. Ricky Bloomfield, chief medical officer at Oura. "As we take on a bigger role in healthcare with new use cases, partnerships, and levels of clinical evidence, that trust has to be earned at every step. We do that by ensuring the right measurement, the right validation, the right outcomes data at every layer. ORCA is how we hold ourselves to that standard, alongside the researchers and institutions we work with." A foundation for validated measurement Outcomes research depends on accurate measurement. Oura Ring has been included in more than 200 peer-reviewed publications spanning sleep, cardiovascular health, women's health, metabolic health, mental health, pregnancy, and other areas, including studies that evaluate its accuracy against established clinical and research reference standards: >
Building on that foundation, ORCA's outcomes research team works with partners to identify clinically meaningful questions and examine how continuous Oura data relates to health outcomes, healthcare utilization, and cost of care. Alongside SMART-BMI, current studies include:
Together, these ORCA-led collaborations extend Oura's research work beyond validating individual measurements to studying their relationship with outcomes across treatment, reproductive health, and recovery. A growing ecosystem of research and care Beyond Oura's own studies, researchers and health systems are independently using Oura Ring across a wide range of health questions. Researchers at hospital systems and academic medical centers have used it in more than 150 studies. Independent examples, conducted separately from Oura and ORCA, include:
Health systems are also beginning to bring Oura data into care delivery. Mount Sinai Doctors-Concierge Care's Healthspan Membership is integrating Oura Ring 5 data to give physicians a continuous view of biometric trends between visits. "The real opportunity is to understand what's happening between visits, how a patient is sleeping, recovering, moving and responding to changes in their daily life," said Fiorina Kyritsi, MD, of Mount Sinai Doctors-Concierge Care. "By bringing those insights into the care relationship, we can have a much more informed conversation with our members." Continuing the momentum As Oura's work in healthcare grows, ORCA is leading education and engagement initiatives through year-end to help clinicians and future medical leaders understand the science behind wearable data and interpret it responsibly in care:
"The path to a meaningful role in healthcare requires the right team, strong science, and a clear commitment to clinical validation and outcomes research," said Tom Hale, chief executive officer at Oura. "We have brought together experts in clinical care, research, regulatory affairs, quality, and informatics to guide that work, alongside research partnerships that help us evaluate our technology against established standards and study its potential in real-world care settings. Together, this foundation will help us earn trust and shape the responsible role continuous health data can play in care." About OURA OURA is a health intelligence platform designed to transform how people understand and manage their health in everyday life. Oura's platform is anchored by Oura Ring, the world's leading smart ring that empowers you to live healthier, longer. Oura supports millions of members worldwide across sleep, activity, stress, readiness, women's health, metabolic health, and heart health. Oura Ring is purpose-built to leverage the finger's unique physiological advantages for photoplethysmography (PPG) measurement, producing a stronger signal than wrist-based wearables. The core metrics of the lightweight Oura Ring are scientifically validated against gold standards and the ring tracks 50+ health metrics continuously, empowering both individuals and thousands of research teams, healthcare providers, sports teams, and organizations. Trusted by an ecosystem of more than 1,200 partners, Oura is advancing the future of preventative health with privacy and security at the forefront. Founded in Finland in 2013, Oura is headquartered in San Francisco with E.U. headquarters in Oulu, Finland. Oura Ring is not a medical device and is not intended to diagnose, treat, cure, monitor, or prevent medical conditions or illnesses.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261028962556/en/ |

